1. Home
  2. KORE vs ASRT Comparison

KORE vs ASRT Comparison

Compare KORE & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KORE Group Holdings Inc.

KORE

KORE Group Holdings Inc.

N/A

Current Price

$8.96

Market Cap

89.6M

ML Signal

N/A

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

N/A

Current Price

$11.61

Market Cap

76.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
KORE
ASRT
Founded
2003
1995
Country
United States
United States
Employees
539
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
89.6M
76.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
KORE
ASRT
Price
$8.96
$11.61
Analyst Decision
Hold
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$35.00
AVG Volume (30 Days)
143.7K
29.7K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
95.07
EPS
N/A
N/A
Revenue
N/A
$124,961,000.00
Revenue This Year
$1.26
N/A
Revenue Next Year
$7.55
$1.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.00
$0.51
52 Week High
$9.00
$12.95

Technical Indicators

Market Signals
Indicator
KORE
ASRT
Relative Strength Index (RSI) 89.43 53.65
Support Level $4.67 $11.05
Resistance Level N/A $12.75
Average True Range (ATR) 0.11 0.45
MACD 0.29 -0.17
Stochastic Oscillator 99.05 52.41

Price Performance

Historical Comparison
KORE
ASRT

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: